Antitumor therapy comprising distamycin derivatives

Details Antitumor therapy comprising distamycin derivatives Antitumor therapy comprising distamycin derivatives

2008-07-15

2008-07-15

Kam, Chih-Min (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S428000, C514S422000, C514S408000, C544S333000, C548S524000, C548S518000, C548S314700

Reexamination Certificate

active

07399748

ABSTRACT:
The present invention relates to an administration schedule comprising the intravenous administration of a α-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.

REFERENCES:
patent: 6576612 (2003-06-01), Fowst et al.
patent: 0 388 948 (1990-09-01), None
patent: WO 98 04524 (1998-02-01), None
patent: WO 99 50265 (1999-10-01), None
patent: WO 01 40181 (2001-06-01), None

Affiliated with

Also associated with

Rating

Antitumor therapy comprising distamycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor therapy comprising distamycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor therapy comprising distamycin derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2765800